Solunum Sistemi
Özet
Referanslar
Barnes, P. J. (2020). Inhaled corticosteroids in COPD: A case in favour. European Respiratory Journal, 55(5), 1902104. https://doi.org/10.1183/13993003.02104-2019
Bojic, T., & Kadija, M. (2021). Advances in chronic obstructive pulmonary disease. Annals of Translational Medicine, 9(7), 579. https://doi.org/10.21037/atm-21-79
Brassington, K., & King, J. (2021). Acute respiratory distress syndrome: A review. BMJ, 372, n158. https://doi.org/10.1136/bmj.n158
Chalmers, J. D., & Chotirmall, S. H. (2020). Bronchiectasis and the microbiome. European Respiratory Journal, 55(1), 1901202. https://doi.org/10.1183/13993003.01202-2019
Duffy, S. P., & Crichton, M. L. (2021). Novel approaches to the treatment of pulmonary fibrosis. Respiratory Research, 22(1), 54. https://doi.org/10.1186/s12931-021-01690-4
Fabbri, L. M., & Rabe, K. F. (2020). From COPD to chronic systemic inflammatory syndrome? The Lancet, 395(10240), 937-939. https://doi.org/10.1016/S0140-6736(20)30157-8
Gibson, P. G., & McDonald, V. M. (2020). Asthma-COPD overlap 2020: Now we are six. Thorax, 75(1), 6-8. https://doi.org/10.1136/thoraxjnl-2019-213807
Hogg, J. C., & Pare, P. D. (2021). Pathology of small airways disease in COPD. Thorax, 76(10), 998-1005. https://doi.org/10.1136/thoraxjnl-2021-216938
Kim, V., & Criner, G. J. (2020). Chronic bronchitis and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 201(2), 167-175. https://doi.org/10.1164/rccm.201908-1556CI
King, T. E., & Pardo, A. (2020). Idiopathic pulmonary fibrosis: Clinical relevance of genetic susceptibility. The Lancet Respiratory Medicine, 8(5), 489-498. https://doi.org/10.1016/S2213-2600(19)30492-2
Mannino, D. M., & Buist, A. S. (2020). Global burden of COPD: Risk factors, prevalence, and future trends. The Lancet, 370(9589), 765-773. https://doi.org/10.1016/S0140-6736(07)61380-4
Papi, A., & Brightling, C. (2020). Asthma. The Lancet, 396(10265), 1075-1086. https://doi.org/10.1016/S0140-6736(20)31397-1
Richeldi, L., & Rubin, A. S. (2020). Idiopathic pulmonary fibrosis: Current treatment options and future directions. The Lancet, 395(10229), 1943-1954. https://doi.org/10.1016/S0140-6736(20)30558-2
Siafakas, N. M., & Anagnostopoulos, G. K. (2020). Bronchiectasis: Pathogenesis, treatment, and challenges. American Journal of Respiratory and Critical Care Medicine, 201(11), 1377-1392. https://doi.org/10.1164/rccm.201908-1501PP
Sin, D. D., & Man, S. P. (2020). Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation, 112(3), 327-334. https://doi.org/10.1161/CIRCULATIONAHA.104.506634
Thompson, A. B., & Rizzo, M. (2021). Pulmonary rehabilitation for chronic respiratory diseases. American Journal of Respiratory and Critical Care Medicine, 204(2), 120-136. https://doi.org/10.1164/rccm.202011-4082CI
Vestbo, J., & Hurd, S. S. (2020). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine, 203(2), 157-165. https://doi.org/10.1164/rccm.201204-0596PP
Wang, C., & Xu, J. (2021). Chronic respiratory diseases and COVID-19: Current evidence and knowledge gaps. The Lancet Respiratory Medicine, 9(7), 663-673. https://doi.org/10.1016/S2213-2600(20)30551-0
Weiss, S. T., & Raby, B. A. (2020). Asthma genetics 2020: GWAS informs therapy. The Journal of Allergy and Clinical Immunology, 145(3), 765-772. https://doi.org/10.1016/j.jaci.2019.11.036
Zhou, F., & Yu, T. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet, 395(10229), 1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3
Referanslar
Barnes, P. J. (2020). Inhaled corticosteroids in COPD: A case in favour. European Respiratory Journal, 55(5), 1902104. https://doi.org/10.1183/13993003.02104-2019
Bojic, T., & Kadija, M. (2021). Advances in chronic obstructive pulmonary disease. Annals of Translational Medicine, 9(7), 579. https://doi.org/10.21037/atm-21-79
Brassington, K., & King, J. (2021). Acute respiratory distress syndrome: A review. BMJ, 372, n158. https://doi.org/10.1136/bmj.n158
Chalmers, J. D., & Chotirmall, S. H. (2020). Bronchiectasis and the microbiome. European Respiratory Journal, 55(1), 1901202. https://doi.org/10.1183/13993003.01202-2019
Duffy, S. P., & Crichton, M. L. (2021). Novel approaches to the treatment of pulmonary fibrosis. Respiratory Research, 22(1), 54. https://doi.org/10.1186/s12931-021-01690-4
Fabbri, L. M., & Rabe, K. F. (2020). From COPD to chronic systemic inflammatory syndrome? The Lancet, 395(10240), 937-939. https://doi.org/10.1016/S0140-6736(20)30157-8
Gibson, P. G., & McDonald, V. M. (2020). Asthma-COPD overlap 2020: Now we are six. Thorax, 75(1), 6-8. https://doi.org/10.1136/thoraxjnl-2019-213807
Hogg, J. C., & Pare, P. D. (2021). Pathology of small airways disease in COPD. Thorax, 76(10), 998-1005. https://doi.org/10.1136/thoraxjnl-2021-216938
Kim, V., & Criner, G. J. (2020). Chronic bronchitis and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 201(2), 167-175. https://doi.org/10.1164/rccm.201908-1556CI
King, T. E., & Pardo, A. (2020). Idiopathic pulmonary fibrosis: Clinical relevance of genetic susceptibility. The Lancet Respiratory Medicine, 8(5), 489-498. https://doi.org/10.1016/S2213-2600(19)30492-2
Mannino, D. M., & Buist, A. S. (2020). Global burden of COPD: Risk factors, prevalence, and future trends. The Lancet, 370(9589), 765-773. https://doi.org/10.1016/S0140-6736(07)61380-4
Papi, A., & Brightling, C. (2020). Asthma. The Lancet, 396(10265), 1075-1086. https://doi.org/10.1016/S0140-6736(20)31397-1
Richeldi, L., & Rubin, A. S. (2020). Idiopathic pulmonary fibrosis: Current treatment options and future directions. The Lancet, 395(10229), 1943-1954. https://doi.org/10.1016/S0140-6736(20)30558-2
Siafakas, N. M., & Anagnostopoulos, G. K. (2020). Bronchiectasis: Pathogenesis, treatment, and challenges. American Journal of Respiratory and Critical Care Medicine, 201(11), 1377-1392. https://doi.org/10.1164/rccm.201908-1501PP
Sin, D. D., & Man, S. P. (2020). Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation, 112(3), 327-334. https://doi.org/10.1161/CIRCULATIONAHA.104.506634
Thompson, A. B., & Rizzo, M. (2021). Pulmonary rehabilitation for chronic respiratory diseases. American Journal of Respiratory and Critical Care Medicine, 204(2), 120-136. https://doi.org/10.1164/rccm.202011-4082CI
Vestbo, J., & Hurd, S. S. (2020). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine, 203(2), 157-165. https://doi.org/10.1164/rccm.201204-0596PP
Wang, C., & Xu, J. (2021). Chronic respiratory diseases and COVID-19: Current evidence and knowledge gaps. The Lancet Respiratory Medicine, 9(7), 663-673. https://doi.org/10.1016/S2213-2600(20)30551-0
Weiss, S. T., & Raby, B. A. (2020). Asthma genetics 2020: GWAS informs therapy. The Journal of Allergy and Clinical Immunology, 145(3), 765-772. https://doi.org/10.1016/j.jaci.2019.11.036
Zhou, F., & Yu, T. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet, 395(10229), 1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3
